ENvue Medical (FEED) Share-based Compensation (2014 - 2024)
ENvue Medical's (FEED) quarterly Share-based Compensation came in at $191000.0 in Q4 2024, down 99.93% year-on-year from $292.8 million in Q1 2024, and up 582.14% on a QoQ basis from $28000.0 in Q3 2024.
ENvue Medical (FEED) Share-based Compensation (2014 - 2024) Analysis & Trends
ENvue Medical (FEED) has 11 years of Share-based Compensation data on file, last reported at $191000.0 in Q4 2024.
- On a quarterly basis, Share-based Compensation fell 99.93% year-over-year to $191000.0 in Q4 2024; TTM through Mar 2025 was $247000.0, a 99.92% decrease from a year earlier, with the FY2024 full-year figure at $356000.0, down 99.88% from the prior year.
- Share-based Compensation for Q4 2024 stood at $191000.0, up from $28000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for FEED reached as high as $292.8 million in Q4 2023 and fell as low as -$190000.0 in Q4 2020.
- Historically, Share-based Compensation has averaged $14.7 million across 5 years, with a median of $77500.0 in 2020.
- Across the five-year window, Share-based Compensation tumbled 136.19% in 2022 and surged 301987.63% in 2023, its largest moves.
- Year by year, Share-based Compensation stood at -$190000.0 in 2020, then jumped by 241.05% to $268000.0 in 2021, then plunged by 136.19% to -$97000.0 in 2022, then jumped by 301987.63% to $292.8 million in 2023, then slumped by 99.93% to $191000.0 in 2024.
- Per Business Quant data, the three most recent Share-based Compensation figures were $191000.0 in Q4 2024, $28000.0 in Q3 2024, and $28000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ENvue Medical | 10,254.30 | -2.25 Mn | -55,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 191,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 107,000.00 |
| Mar 31, 2024 | 107,000.00 |
| Dec 31, 2023 | 292.83 Mn |
| Dec 31, 2023 | 292.83 Mn |
| Sep 30, 2023 | 36,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | -97,000.00 |
| Dec 31, 2022 | -97,000.00 |
| Sep 30, 2022 | 116,000.00 |
| Sep 30, 2022 | 116,000.00 |